SUNPHARMA had a positive weekly return of 2.27%, outperforming peers DRREDDY and HINDUNILVR, but underperforming DIVISLAB. The stock's volatility was relatively moderate at 16.12%, lower than its peers. With a Sharpe Ratio of 0.56, the stock's return was decent considering the risk taken. Overall, SUNPHARMA was a relatively stable and attractive option this week.

[Volatility: 16.12%]